Trials / Not Yet Recruiting
Not Yet RecruitingNCT07471230
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
Phase II Randomized Controlled Trial Evaluating Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Biocells Medical · Industry
- Sex
- All
- Age
- 48 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism. The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments targeting neurodegeneration within dopaminergic pathways.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Intrathecal (IT) | Intrathecal injection of 3 ml between L4-L5 |
| BIOLOGICAL | Intravenous | Intravenous injection via a drip |
Timeline
- Start date
- 2026-11-23
- Primary completion
- 2028-11-23
- Completion
- 2029-11-23
- First posted
- 2026-03-13
- Last updated
- 2026-03-13
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT07471230. Inclusion in this directory is not an endorsement.